A radioimmunoassay for 6-keto-prostaglandin F1 alpha.

  • L. M. Demers
  • , D. D. Derck

Research output: Contribution to journalArticlepeer-review

Abstract

We describe a highly specific RIA for blood and urine 6-keto-PGF1 alpha, the principal metabolite of PGI2. The method requires extraction and column chromatography prior to assay and uses a tritium trace for assay monitoring. Dextran-coated charcoal is used to separate bound from free trace. Acceptable standard curve reproducibility over six assays had a mean correlation of 0.991 with a coefficient of variation of 6.61%. Good precision and accuracy data were generated with this assay, and normal human blood levels in 80 control subjects was less than 125 pg/ml. Significant elevations of blood 6-keto-PGF1 alpha were found in a high proportion of cancer patients with various solid tumor malignancies.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalAdvances in prostaglandin and thromboxane research
Volume6
StatePublished - 1980

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'A radioimmunoassay for 6-keto-prostaglandin F1 alpha.'. Together they form a unique fingerprint.

Cite this